Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF)
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (2) , 188-192
- https://doi.org/10.1016/0959-8049(94)00432-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcomaThe Lancet, 1993
- AIDS-associated mucocutaneous Kaposiʼs sarcoma treated with bleomycinAIDS, 1992
- Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte—macrophage colony-stimulating factor in the treatment of AIDS-related Kaposiʼs sarcomaAIDS, 1992
- Kaposiʼs sarcoma in HIV infection treated with vincristine and bleomycinAIDS, 1992
- Cellular and molecular features of HIV-associated Kaposiʼs sarcomaAIDS, 1992
- Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?The Lancet, 1990
- CLINICAL AND VIROLOGICAL EFFECTS OF HIGH-DOSE RECOMBINANT INTERFERON-α IN DISSEMINATED AIDS-RELATED KAPOSI'S SARCOMAThe Lancet, 1988
- Peripheral neuropathy in the acquired immunodeficiency syndromeAnnals of Neurology, 1988
- Aids-associated kaposiʼs sarcomaAIDS, 1988
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987